HEMALASI ApS: Financial statements 2024
CVR: 42924016
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
HEMALASI ApS (CVR 42924016) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 294,659 and a net result of DKK 213,974 compared with DKK 315,803 the year before. That is a decrease of 33.6% compared with the year before. Equity in the 2024 report amounted to DKK 588,294. The solvency ratio was 88%.
- Gross Profit
- DKK 294,659
- Profit/Loss
- DKK 213,974
- Equity
- DKK 588,294
- Total Assets
- DKK 668,502
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 295 t. | 214 t. | 588 t. | - |
| 2023 | - | 443 t. | 316 t. | 572 t. | - |
| 2022 | - | - | 426 t. | 466 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
HEMALASI ApS has published its annual report for 2023. Gross profit came to DKK 443,482, and the net result was DKK 315,803.
About HEMALASI ApS
HEMALASI ApS is a Danish company of the type Anpartsselskab based in Hedensted, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Lars Zederkof. The company's owners include Helle Laursen, Lars Zederkof and Signe Forsberg Zederkof. In 2025, the company reported a gross profit of DKK 143,121 and a net result of DKK 71,105 compared with DKK 213,974 the year before. Equity in the 2025 report amounted to DKK 539,399.